title: [The relation between positive rate of autoantibodies against beta1 and M2-adrenergic receptors and urinary albumin excretion rate in the type 2 diabetes mellitus with refractory hypertension].
abstract: OBJECTIVE
  To explore the relation between the positive rates of autoantibodies against beta(1) adrenergic receptor (beta1-receptor)and (M2-receptor) with urinary albumin excretion rate (UAER) in type 2 diabetes patients with refractory hypertension.
  
  
  METHODS
  Autoantibodies against beta(1)- and M(2)-receptor as well as autoantibodies were determined in type 2 diabetes patients with (n = 136) or without (n = 111) refractory hypertension, hypertensive patients without renal failure (n = 60) and healthy control subjects (n = 40, control) by ELISA.
  
  
  RESULTS
  The positive rates of the autoantibodies against beta1-receptors (44.9%) and M(2)-receptor (37.5%) in patients with type 2 diabetes with refractory hypertension were significantly higher than those in patients with type 2 diabetes without refractory hypertension (27.9% and 24.3%, respectively, all P < 0.05), in patients with hypertension without renal failure (11.7% and 15.0%, all P < 0.01) and in healthy controls (8.3% and 7.5%, all P < 0.01). In type 2 diabetes patients with refractory hypertension and renal failure (UAER > or = 200 microg/min), the positive rates of the autoantibodies against beta(1)-receptor (87.1%, 27/31) and against M(2)-receptor (67.7%, 21/31) were significantly higher than those in type 2 diabetes patients with refractory hypertension but without renal failure (UAER 20 - 199 microg /min, 46.7%, 28/60 and 41.7%, 25/60, respectively, all P < 0.05).
  
  
  CONCLUSIONS
  The serum beta(1)- and M (2)-receptor autoantibodies are positively associated with the UAER level and suggest that these autoantibodies against beta(1) and M(2)-receptor may play important roles in the pathogenesis of the type 2 diabetes with refractory hypertension.
authors.affiliation: Wu Han Hospital of Guang Zhou Military Region PLA, Wuhan 430070, China.
authors.forename: Lin-shuang
authors.initials: LS
authors.lastname: Zhao
authors.forename: Yu-hua
authors.initials: YH
authors.lastname: Liao
authors.forename: Guang-da
authors.initials: GD
authors.lastname: Xiang
authors.forename: Min
authors.initials: M
authors.lastname: Wang
authors.forename: Ling
authors.initials: L
authors.lastname: LE
authors.forename: Zi-hua
authors.initials: ZH
authors.lastname: Zhou
authors.forename: Xuan
authors.initials: X
authors.lastname: Lin
authors.forename: Hui-ling
authors.initials: HL
authors.lastname: Sun
mesh_terms: D000368:Aged; D000419:Albuminuria / Q000209:etiology*; D001323:Autoantibodies / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000276:immunology*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D043585:Receptor, Muscarinic M2 / Q000276:immunology; D018342:Receptors, Adrenergic, beta-1 / Q000276:immunology
chemical_list: D001323:Autoantibodies; D043585:Receptor, Muscarinic M2; D018342:Receptors, Adrenergic, beta-1